AL
Anemo Labs
United Kingdom · Healthtech · AI
Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening.
Product and customers
Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening.
Its olfactory chip is designed to detect multiple volatile organic compounds in parallel. The current work targets biomarker screening in urine, sweat and other bodily fluids; the company describes the technology as being in development.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | £700K | SFC Capital — LeadZinc — Lead |